Tissue Regenix Group PLC
LSE:TRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tissue Regenix Group PLC
LSE:TRX
|
UK |
|
C
|
Curzio Research Inc
OTC:CURZ
|
US |
|
R
|
Riverfort Global Opportunities PLC
LSE:RGO
|
UK |
|
Societe LDC SA
PAR:LOUP
|
FR |
|
Praemium Ltd
ASX:PPS
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TRX's stock price target?
Not Available
TRX doesn't have any price targets made by Wall Street professionals.
What is Tissue Regenix Group PLC's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Tissue Regenix Group PLC's revenue is
53%.
The projected
CAGR
for the next 2 years is
9%.
What is Tissue Regenix Group PLC's Operating Income forecast?
Projected CAGR
137%
The
compound annual growth rate
of
Tissue Regenix Group PLC's operating income for the next 2 years is
137%.